Literally dozens of pharmaceutical companies have disappeared over the last 20 years, not just small companies, but major ones like Upjohn, Pharmacia, Searle, Warner-Lambert and Schering-Plough. They have disappeared for excellent business reasons. But as a result, at a time when there is an explosion in the understanding of the cause of diseases, industry contraction has resulted in fewer scientists pursuing these new insights. In the long term, that doesn’t benefit the world’s health.
Une culture d’entreprise peut-elle être un frein à la transformation digitale? Une chose est sûre : transformation digitale et culture d’entreprise doivent évoluer de concert pour que ce soit réellement bénéfique pour l’entreprise. La transformation digitale est un sujet à l’agenda des dirigeants de beaucoup d’organisations depuis quelques années. Il …
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs.
This is one of the longest exclusivity terms provided by the FDA. Only orphan drugs receive a longer term of exclusivity, although the five years granted under the Generating Antibiotic Incentives Now (GAIN) Act may be added in addition to other exclusivities, giving it an effetively longer span.
This chart shows the companies which have received the most new chemical entity exclusivities in the past five years.
A deeply emotional campaign developed by Ogilvy & Mather for Philips showing people with lung conditions like cystic fibrosis and COPD learning how to sing and performing at the Apollo Theater won the pharma Grand Prix at the Cannes Lions Health festival of creativity.
The campaign, called Breathless Choir and set to Sting's “Every Breath You Take,” seeks to raise awareness about COPD. The 18 choir participants, each of whom has a respiratory condition that can limit their ability to talk or breath, used a Philips SimplyGo Mini, a portable oxygen concentrator.
The campaign is a departure in many ways from traditional medical device marketing, which often relies on the technical mechanics of how a device works. In this campaign the product is visible but it is not the focus of the film. Royal Philips has a long history of marketing healthcare products but it also sells electronic toothbrushes, baby monitors, and other consumer products. This may be one reason why the company was interested in marketing a medical device in this manner, von Plato noted.
This is the third year that Cannes Lions has held Lions Health, the specialty healthcare segment of the festival. The first year the jury declined to award a Grand Prix, citing the quality of the entries. Last year an unbranded campaign for AstraZeneca and developed by DigitasLBi called Take It From a Fish won the top prize.
[Meanwhile, AstraZeneca pulled the Take it From a Fish campaign; see "Like 3-Day Old Fish, AZ's Take it From a Fish Campaign Had Bad Taste"]
The gold winners are: Teva Neurosciences' ParkinSounds, developed by Havas Life in São Paulo; Aster Healthcare's The Nazar Initiative, developed by the Classic Partnership Advertising in Dubai; Last Words for the Indian Association of Palliative Care, developed by Medulla Communications; and Pfizer's branded-print campaign for Xalatan eyedrops, developed by McCann Health Hong Kong.
Most physicians do not seem to know that "there is no such thing as a free lunch." Medscape's 2012 Ethics Report survey, for example, revealed that 72% of 23,710 physician respondents answered "Yes" to the question "Do you feel that you could be unbiased with prescribing habits if you accept lunches from pharmaceutical representatives?" (see here).
But, according to other researchers, such thinking is a "slippery slope" on which "Physicians fail to recognize their vulnerability to commercial influences due to self-serving bias, rationalization, and cognitive dissonance" (see "Physicians Under Pharma's Influence: Are Physicians Powerless Pawns of Pharma Psychology?").
Time and time again, when I write about physicians getting free lunches delivered by sales reps, someone always comes forward and says something like "It's ridiculous to think that I can be influenced by a $10 lunch!"
But what if it was a $20 lunch? More recent research indicates those lunches have significant ROI in terms of prescribing brand name drugs.
Read more about that research here.
Du 20 juin au 1er juillet 2016, l'Afipa (Association française de l’industrie pharmaceutique pour une automédication responsable) lance « Ma santé mon choix : la minute info de l’automédication responsable », une opération de communication grand public à vocation pédagogique sur l’automédication responsable.
L'ex président du CNNUM, Benoît Thieulin, partage désormais son temps entre son agence de communication la Netscouade, où il s’occupe de transformation numérique et d’innovation, et l’école de la communication de Sciences Po, où il construit un projet d’école du numérique.
Pour lui, trois secteurs ne sont pas encore disruptés : la santé, l’éducation et la politique, domaine en fait le plus réglementé où tout reste à faire.
Car si le monde économique a compris la transformation en cours, les politiques eux doivent désormais pratiquer le numérique pour le comprendre.